132 related articles for article (PubMed ID: 3876055)
1. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
Das SN; Khanna NN; Khanna S
Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.
Das SN; Khanna NN; Khanna S
Cancer Invest; 1986; 4(3):207-16. PubMed ID: 3719410
[TBL] [Abstract][Full Text] [Related]
3. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
[TBL] [Abstract][Full Text] [Related]
4. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
5. Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.
Wanebo HJ; Rosen PP; Thaler T; Urban JA; Oettgen HF
Ann Surg; 1976 Sep; 184(3):258-67. PubMed ID: 962394
[TBL] [Abstract][Full Text] [Related]
6. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
[TBL] [Abstract][Full Text] [Related]
7. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
8. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
[TBL] [Abstract][Full Text] [Related]
9. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
10. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
11. Immunocompetence and malignant lymphoma: immunologic status before therapy.
Anderson TC; Jones SE; Soehnlen BJ; Moon TE; Griffith K; Stanley P
Cancer; 1981 Dec; 48(12):2702-9. PubMed ID: 6458352
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: a 10 year study.
Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
Cancer Immunol Immunother; 1986; 21(1):6-11. PubMed ID: 3632917
[TBL] [Abstract][Full Text] [Related]
13. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
[No Abstract] [Full Text] [Related]
15. Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2061-73. PubMed ID: 7370952
[TBL] [Abstract][Full Text] [Related]
16. Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma.
Lee YT
J Surg Oncol; 1984 Nov; 27(3):135-40. PubMed ID: 6492808
[TBL] [Abstract][Full Text] [Related]
17. Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.
Stein JA; Adler A; Efraim SB; Maor M
Cancer; 1976 Sep; 38(3):1171-87. PubMed ID: 953963
[TBL] [Abstract][Full Text] [Related]
18. [The immune competence of patients with Crohn's disease (author's transl)].
Tönnesmann E; Bürkle PA; Schäfer B; Federlin K
Klin Wochenschr; 1979 Oct; 57(20):1097-107. PubMed ID: 513603
[TBL] [Abstract][Full Text] [Related]
19. Blood lymphocyte counts with subset analysis in operable breast cancer. Relation to the extent of tumor disease and prognosis.
Rotstein S; Blomgren H; Petrini B; Wasserman J; Nilsson B; Baral E
Cancer; 1985 Sep; 56(6):1413-9. PubMed ID: 4027876
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lymphocyte immunity in breast cancer patients.
Head JF; Elliott RL; McCoy JL
Breast Cancer Res Treat; 1993; 26(1):77-88. PubMed ID: 8400326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
